Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses

Monica L. Kasting, Shannon Wilson, Terrell W. Zollinger, Brian Dixon, Nathan Stupiansky, Gregory Zimet

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Among the identified barriers to HPV vaccination is the concern that women may compensate for their reduced susceptibility to cervical cancers by reducing cervical cancer screening. This exploratory study examined the relationship between cervical cancer screening rates and HPV vaccination. We conducted a cross-sectional survey using a convenience sample of women aged 21–35 attending a local minority health fair in July 2015. Data were analyzed in 2015–2016. Outcomes assessed were: receiving a Pap test within the last three years, awareness and comfort with current Pap test recommendations, and knowledge regarding the purpose of a Pap test. A total of 291 women were included in the analyses. Mean age was 28.5 years and 62% were non-Hispanic black. 84% had received a Pap test in the last three years and 33% had received at least one HPV vaccine. Logistic regression results showed that women who had been vaccinated did not have lower odds of having a Pap test in the past three years (OR = 1.32; 95% CI = 0.66–2.65). In an adjusted regression model controlling for age and race, vaccinated women were significantly more likely to have had a Pap test (AOR = 3.06; 95% CI = 1.37–6.83). Yet only 26% of women knew the purpose of a Pap test and the proportion who answered correctly was higher among non-Hispanic white women. Women who have been vaccinated for HPV are more likely to have been screened for cervical cancer. These results suggest areas for more robust studies examining pro-health attitudes, behaviors, and communication regarding vaccination and preventive screening.

Original languageEnglish (US)
Pages (from-to)169-174
Number of pages6
JournalPreventive Medicine Reports
Volume5
DOIs
StatePublished - Mar 1 2017

Fingerprint

Papanicolaou Test
Early Detection of Cancer
Uterine Cervical Neoplasms
Vaccination
Minority Health
Health Fairs
Health Communication
Attitude to Health
Papillomavirus Vaccines
Surveys and Questionnaires
Cross-Sectional Studies
Logistic Models

Keywords

  • Health behaviors
  • Health disparities
  • Papanicolaou test
  • Papillomavirus vaccines
  • Risk compensation

ASJC Scopus subject areas

  • Health Informatics
  • Public Health, Environmental and Occupational Health

Cite this

Differences in cervical cancer screening knowledge, practices, and beliefs : An examination of survey responses. / Kasting, Monica L.; Wilson, Shannon; Zollinger, Terrell W.; Dixon, Brian; Stupiansky, Nathan; Zimet, Gregory.

In: Preventive Medicine Reports, Vol. 5, 01.03.2017, p. 169-174.

Research output: Contribution to journalArticle

@article{4158f8c9d1ef4980b3e6966fbf7c3508,
title = "Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses",
abstract = "Among the identified barriers to HPV vaccination is the concern that women may compensate for their reduced susceptibility to cervical cancers by reducing cervical cancer screening. This exploratory study examined the relationship between cervical cancer screening rates and HPV vaccination. We conducted a cross-sectional survey using a convenience sample of women aged 21–35 attending a local minority health fair in July 2015. Data were analyzed in 2015–2016. Outcomes assessed were: receiving a Pap test within the last three years, awareness and comfort with current Pap test recommendations, and knowledge regarding the purpose of a Pap test. A total of 291 women were included in the analyses. Mean age was 28.5 years and 62{\%} were non-Hispanic black. 84{\%} had received a Pap test in the last three years and 33{\%} had received at least one HPV vaccine. Logistic regression results showed that women who had been vaccinated did not have lower odds of having a Pap test in the past three years (OR = 1.32; 95{\%} CI = 0.66–2.65). In an adjusted regression model controlling for age and race, vaccinated women were significantly more likely to have had a Pap test (AOR = 3.06; 95{\%} CI = 1.37–6.83). Yet only 26{\%} of women knew the purpose of a Pap test and the proportion who answered correctly was higher among non-Hispanic white women. Women who have been vaccinated for HPV are more likely to have been screened for cervical cancer. These results suggest areas for more robust studies examining pro-health attitudes, behaviors, and communication regarding vaccination and preventive screening.",
keywords = "Health behaviors, Health disparities, Papanicolaou test, Papillomavirus vaccines, Risk compensation",
author = "Kasting, {Monica L.} and Shannon Wilson and Zollinger, {Terrell W.} and Brian Dixon and Nathan Stupiansky and Gregory Zimet",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.pmedr.2016.12.013",
language = "English (US)",
volume = "5",
pages = "169--174",
journal = "Preventive Medicine Reports",
issn = "2211-3355",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Differences in cervical cancer screening knowledge, practices, and beliefs

T2 - An examination of survey responses

AU - Kasting, Monica L.

AU - Wilson, Shannon

AU - Zollinger, Terrell W.

AU - Dixon, Brian

AU - Stupiansky, Nathan

AU - Zimet, Gregory

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Among the identified barriers to HPV vaccination is the concern that women may compensate for their reduced susceptibility to cervical cancers by reducing cervical cancer screening. This exploratory study examined the relationship between cervical cancer screening rates and HPV vaccination. We conducted a cross-sectional survey using a convenience sample of women aged 21–35 attending a local minority health fair in July 2015. Data were analyzed in 2015–2016. Outcomes assessed were: receiving a Pap test within the last three years, awareness and comfort with current Pap test recommendations, and knowledge regarding the purpose of a Pap test. A total of 291 women were included in the analyses. Mean age was 28.5 years and 62% were non-Hispanic black. 84% had received a Pap test in the last three years and 33% had received at least one HPV vaccine. Logistic regression results showed that women who had been vaccinated did not have lower odds of having a Pap test in the past three years (OR = 1.32; 95% CI = 0.66–2.65). In an adjusted regression model controlling for age and race, vaccinated women were significantly more likely to have had a Pap test (AOR = 3.06; 95% CI = 1.37–6.83). Yet only 26% of women knew the purpose of a Pap test and the proportion who answered correctly was higher among non-Hispanic white women. Women who have been vaccinated for HPV are more likely to have been screened for cervical cancer. These results suggest areas for more robust studies examining pro-health attitudes, behaviors, and communication regarding vaccination and preventive screening.

AB - Among the identified barriers to HPV vaccination is the concern that women may compensate for their reduced susceptibility to cervical cancers by reducing cervical cancer screening. This exploratory study examined the relationship between cervical cancer screening rates and HPV vaccination. We conducted a cross-sectional survey using a convenience sample of women aged 21–35 attending a local minority health fair in July 2015. Data were analyzed in 2015–2016. Outcomes assessed were: receiving a Pap test within the last three years, awareness and comfort with current Pap test recommendations, and knowledge regarding the purpose of a Pap test. A total of 291 women were included in the analyses. Mean age was 28.5 years and 62% were non-Hispanic black. 84% had received a Pap test in the last three years and 33% had received at least one HPV vaccine. Logistic regression results showed that women who had been vaccinated did not have lower odds of having a Pap test in the past three years (OR = 1.32; 95% CI = 0.66–2.65). In an adjusted regression model controlling for age and race, vaccinated women were significantly more likely to have had a Pap test (AOR = 3.06; 95% CI = 1.37–6.83). Yet only 26% of women knew the purpose of a Pap test and the proportion who answered correctly was higher among non-Hispanic white women. Women who have been vaccinated for HPV are more likely to have been screened for cervical cancer. These results suggest areas for more robust studies examining pro-health attitudes, behaviors, and communication regarding vaccination and preventive screening.

KW - Health behaviors

KW - Health disparities

KW - Papanicolaou test

KW - Papillomavirus vaccines

KW - Risk compensation

UR - http://www.scopus.com/inward/record.url?scp=85007134515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007134515&partnerID=8YFLogxK

U2 - 10.1016/j.pmedr.2016.12.013

DO - 10.1016/j.pmedr.2016.12.013

M3 - Article

AN - SCOPUS:85007134515

VL - 5

SP - 169

EP - 174

JO - Preventive Medicine Reports

JF - Preventive Medicine Reports

SN - 2211-3355

ER -